> Common Blood Pressure Drug Supercharges Cancer Treatment in Surprising New Study

Researchers at Dartmouth Cancer Center (DCC) have discovered that telmisartan, an FDA-approved medication commonly used to treat hypertension, can significantly enhance the tumor-killing effects of the targeted cancer drug olaparib.

https://scitechdaily.com/common-blood-pressure-drug-supercharges-cancer-treatment-in-surprising-new-study/